绝经期女性冠状动脉微血管功能障碍
本文综述绝经期女性冠状动脉微血管功能障碍(CMD)的现状与证据缺口。CMD 在女性中更常见,与主要不良心血管事件和死亡风险增加相关;绝经期激素和代谢变化加速血管老化、导致内皮功能障碍。现有临床实践多依赖男性为主或混合队列证据,可能造成女性风险分层不当、治疗副作用及预后不良,亟需针对性别差异的诊断阈值与模型。
要点
- CMD 在女性中比男性更常见,与主要不良心血管事件和死亡风险增加相关。
- 绝经期激素变化和代谢改变加速血管老化,导致内皮功能障碍。
- 现有证据多来自男性为主或混合队列,可能影响女性风险分层与预后。
核心结论
- CMD 是绝经期女性中的突出问题,可导致慢性冠状动脉综合征,但性别特异性病理生理证据不足。
- 当前临床实践依赖男性为主或混合队列证据,可能导致女性风险分层不当、治疗副作用和预后不良。
研究设计与样本
- 本文为综述,围绕绝经期女性 CMD 的病理生理、临床关联与证据缺口进行汇总。
主要发现
- CMD 在女性中比男性更常见,并与主要不良心血管事件和死亡风险增加相关。
- 绝经期激素变化和代谢改变加速血管老化,导致内皮功能障碍。
- Takotsubo 综合征和射血分数保留的心力衰竭(HFpEF)患者中很大比例为合并 CMD 的绝经期女性。
- CMD 性别特异性病理生理证据有限,现有临床实践依赖男性为主或混合队列证据。
- 针对 CMD 诊断技术性别差异效能的研究有限,需要量身定制的诊断阈值和模型。
临床怎么用
- 临床应关注绝经期女性 CMD 导致慢性冠状动脉综合征的可能,并重视其不良事件风险。
- 现有证据多来自男性为主或混合队列,用于女性时需警惕风险分层不当和治疗副作用。
- 需进一步研究性别特异性诊断阈值和模型,以改善女性预后。
局限性
- CMD 性别特异性病理生理证据有限,机制尚未完全阐明。
- 针对诊断技术性别差异效能的研究有限。
- 现有临床实践证据多来自男性为主或混合队列。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cardiovascular disease (CVD) accounts for a third of all deaths, making it the leading cause of mortality globally. Coronary microvascular dysfunction (CMD) has emerged as a prominent condition in menopausal women, leading to the development of chronic coronary syndrome (CCS). Despite the significant impact on this cohort, research gaps persist which can lead to shortcomings in the delivery of care to women. CMD is more prevalent in women than men and is linked to increased risk of major adverse cardiovascular events and mortality. During the menopausal transition, there is an acceleration in vascular ageing due to hormonal shift and metabolic changes, resulting in endothelial dysfunction. A large proportion of patients with Takotsubo syndrome and heart failure with preserved ejection fraction (HFpEF) are menopausal women with CMD; however, the underlying mechanisms are not fully understood. Limited evidence of the sex-specific pathophysiology of CMD has resulted in current clinical practice relying on evidence from male-dominant or mixed cohorts. This can lead to incorrect risk stratification, treatment side effects and poor prognosis in women. In addition, there is limited research on the efficacy of diagnostic techniques addressing the sex differences in those with CMD. Tailored diagnostic thresholds and models are essential to improve prognosis in women. Further evidence is needed to bridge these knowledge gaps to tackle the sex differences, achieve sex equality in CVD research and reduce the disproportionate burden of microvascular dysfunction in menopausal women.
引用
- Mathew D, Wang W, Kunadian V, et al. Coronary microvascular dysfunction in menopausal women. Heart. 2026. PMID: 42331611. doi:10.1136/heartjnl-2026-328124
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。